Quote On Cadila Healthcare 3QFY21 By Yash Gupta, Angel Broking
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Cadila reported numbers inline expectation, Cadila Healthcare limited total revenue from operations for Q3FY21 stood at ₹3,754 crores up by 6% YoY from ₹3,541crores in Q3FY20. EBITDA for Q3FY21 stood at ₹807 crores up by 16% as compared to ₹695 crores in Q3FY20. Profit after tax for the quarter up by 41% at 527₹ crores in Q3FY21 as compared to ₹373 crores in Q3FY20.
Company’s domestic business posted strong growth during the quarter grew by 20% on a y-o-y basis and registered revenues of ₹1,643 crore while USA business growth slightly lower than the expected, USA formulation business registered revenue of ₹1603 crores. We have a Positive outlook towards Cadila healthcare limited.
Above views are of the author and not of the website kindly read disclaimer
Tag News
On the higher side, immediate resistance is seen around 36000 - 36200 levels - Angel One
